• The New Money
  • Posts
  • $101 Million for Longevity, Gold on the Blockchain, and Psychedelics For Mental Health & Beyond

$101 Million for Longevity, Gold on the Blockchain, and Psychedelics For Mental Health & Beyond

Uncovering the world’s most exciting early stage companies. Discover what’s next.

December 12, 2023

The $101 Million Dollar Prize For Longevity

XPRIZE has launched a new $101 million prize to incentivize the development of breakthrough therapeutics for longevity. The funding for the prize is being led by co-sponsor Hevolution Foundation and Chip Wilson’s charity Solve FSHD. Participants can develop any type of drug, biologic or device, but it must demonstrate that within twelve months of beginning the treatment it reverses ageing by 20 years.

The Public Company Putting Gold on the Blockchain

Wellfield Technologies (TSX:WFLD) is preparing to launch their tokenized gold ecosystem onto the Ethereum blockchain. The company will leverage the infrastructure of their wholly-owned subsidiary Tradewind Markets to enable decentralized spot trading and fractionalized ownership of gold to both individuals and institutions.

New Psychedelic Trial Shows Promise For Mental Health and Beyond

Gilgamesh Pharma has announced positive results from their Phase 1 trial of GM-2505, a novel 5-HT2A receptor agonist. Originally developed for Major Depressive Disorder and Treatment Resistant Depression, the trial has demonstrated it may also have therapeutic potential for alcohol use disorder, anxiety disorder and obsessive compulsive disorder.

The Sprint